Logo image of ALLO

ALLOGENE THERAPEUTICS INC (ALLO) Stock Earnings & Estimates

NASDAQ:ALLO - US0197701065 - Common Stock

1.13 USD
-0.05 (-4.24%)
Last: 8/29/2025, 8:06:08 PM
1.16 USD
+0.03 (+2.65%)
After Hours: 8/29/2025, 8:06:08 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ALLO revenue by date.ALLO revenue by date.
240K
-99.38%
95K
-60.42%
22K
-76.84%
11.332K
-48.49%
22.664K
100.00%
32.761M
144,448.28%
166.72M
408.90%
388.23M
132.86%
710.03M
82.89%
994.18M
40.02%
1.279B
28.65%
EBITDA
YoY % growth
ALLO ebitda by date.ALLO ebitda by date.
-321.15M
-30.90%
-300.293M
6.49%
-243.843M
18.80%
-227.825M
6.57%
-224.708M
1.37%
-298.676M
-32.92%
-290.639M
2.69%
-219.188M
24.58%
-63.668M
70.95%
N/AN/A
EBIT
YoY % growth
ALLO ebit by date.ALLO ebit by date.
-335.45M
-31.14%
-314.492M
6.25%
-257.482M
18.13%
-236.684M
8.08%
-247.605M
-4.61%
-273.597M
-10.50%
-204.4M
25.29%
-26.641M
86.97%
231.08M
967.38%
411.47M
78.06%
627.62M
52.53%
Operating Margin
ALLO operating margin by date.ALLO operating margin by date.
-139,770.83%-331,044.21%-1,170,372.73%-2,088,600.81%-1,092,485.06%-835.13%-122.60%-6.86%32.55%41.39%49.07%
EPS
YoY % growth
ALLO eps by date.ALLO eps by date.
-2.32
-22.75%
-2.01
13.36%
-1.33
33.83%
-1.01
24.04%
-0.94
6.85%
-1.03
-9.35%
-0.73
29.29%
0.38
151.87%
2.13
464.86%
4.26
100.00%
6.06
42.11%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.23
29.34%
-0.22
20.70%
-0.22
20.86%
-0.23
-0.39%
-0.24
-5.50%
-0.24
-9.96%
Revenue
Q2Q % growth
3.397K3.397K
EBITDA
Q2Q % growth
-53.747M
-6.14%
-51.842M
-10.65%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-54.778M
10.27%
-56.91M
5.92%
-54.755M
16.01%
-57.353M
-5.36%
-60.456M
-10.37%
-61.855M
-8.69%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.23
34.29%
-0.280.0517.55%
Q1 2025
Q2Q % growth
-0.28
26.32%
-0.300.025.26%
Q4 2024
Q2Q % growth
-0.28
34.88%
-0.340.0617.64%
Q3 2024
Q2Q % growth
-0.32
13.51%
-0.340.024.75%
Q2 2024
Q2Q % growth
-0.35
33.96%
-0.350.001.21%
Q1 2024
Q2Q % growth
-0.38
44.12%
-0.420.048.99%
Q4 2023
Q2Q % growth
-0.43
34.85%
-0.460.036.14%
Q3 2023
Q2Q % growth
-0.37
36.21%
-0.530.1630.17%
Q2 2023
Q2Q % growth
-0.53
-1.92%
-0.600.0711.77%
Q1 2023
Q2Q % growth
-0.68
-21.43%
-0.63-0.05-8.03%
Q4 2022
Q2Q % growth
-0.66
-22.22%
-0.710.057.43%
Q3 2022
Q2Q % growth
-0.58
-1.75%
-0.660.0811.76%
Q2 2022
Q2Q % growth
-0.52
1.89%
-0.620.1016.43%
Q1 2022
Q2Q % growth
-0.56
-124.00%
-0.590.034.62%
Q4 2021
Q2Q % growth
-0.54
-1.89%
-0.610.0711.52%
Q3 2021
Q2Q % growth
-0.57
-9.62%
-0.570.000.01%
Q2 2021
Q2Q % growth
-0.53 -0.560.034.97%
Q1 2021
Q2Q % growth
-0.25
50.00%
-0.460.2146.19%
Q4 2020
Q2Q % growth
-0.53
8.62%
-0.570.046.80%
Q3 2020
Q2Q % growth
-0.52
-4.00%
-0.550.035.21%
Q2 2020
Q2Q % growth
-0.53
-29.27%
-0.550.024.01%
Q1 2020
Q2Q % growth
-0.50
-56.25%
-0.590.0915.10%
Q4 2019
Q2Q % growth
-0.58 -0.700.1216.77%
Q3 2019
Q2Q % growth
-0.50 -0.550.058.94%
Q2 2019
Q2Q % growth
-0.41 -0.470.0613.18%
Q1 2019
Q2Q % growth
-0.32 -0.440.1226.59%
ALLO Yearly EPS VS EstimatesALLO Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 -2 4 6
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
1.856K-1.856K-100.00%
Q1 2025
Q2Q % growth

-100.00%
1.856K-1.856K-100.00%
Q4 2024
Q2Q % growth

-100.00%
14.28K-14.28K-100.00%
Q3 2024
Q2Q % growth

-100.00%
13.189K-13.189K-100.00%
Q2 2024
Q2Q % growth

-100.00%
17.248K-17.248K-100.00%
Q1 2024
Q2Q % growth
22K
-57.69%
9.792K12.208K124.67%
Q4 2023
Q2Q % growth
21K
-58.00%
24.041K-3.041K-12.65%
Q3 2023
Q2Q % growth
43K
-14.00%
12.781K30.219K236.45%
Q2 2023
Q2Q % growth
44K
-51.11%
19.268K24.732K128.36%
Q1 2023
Q2Q % growth
52K
-13.33%
10.914K41.086K376.45%
Q4 2022
Q2Q % growth
50K 61.404K-11.404K-18.57%
Q3 2022
Q2Q % growth
50K 14.912K35.088K235.29%
Q2 2022
Q2Q % growth
90K
125.00%
5.661K84.339K1,489.83%
Q1 2022
Q2Q % growth
60K
-99.84%
60K%
Q4 2021
Q2Q % growth
50K -6.324K56.324K890.64%
Q3 2021
Q2Q % growth
50K 14.576K35.424K243.03%
Q2 2021
Q2Q % growth
40K 235.814K-195.814K-83.04%
Q1 2021
Q2Q % growth
38.35M 13.102M25.248M192.70%
Q4 2020
Q2Q % growth
3.23M-3.23M-100.00%
ALLO Yearly Revenue VS EstimatesALLO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS7.6% 34.2% 3.81% 12.43%
Revenue-100% -100% 103.48% -32.09%